Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

ORL1 antagonist J-113397 also being explored for cognition enhancement

Feb. 14, 2000

SCRAS presents new class of NOS inhibitors and antioxidants

Feb. 14, 2000

Pharmacia & Upjohn in discussions with FDA regarding Vestra NDA

Feb. 14, 2000

CGRP gene transfer proves beneficial in rabbit model of subarachnoid hemorrhage

Feb. 11, 2000

Nonanticoagulant heparin derivative attenuates intracerebral hemorrhage-induced brain edema

Feb. 11, 2000

NXY-059 and ciclosporin evaluated for mechanisms underlying neuroprotective effects

Feb. 11, 2000

Warner-Lambert presents new neuroprotective quinoxaline-2-ones

Feb. 11, 2000

CeNeS and Bioglan to codevelop aerosol analgesic

Feb. 11, 2000

Synthesis and use of new CRF antagonists disclosed by DuPont

Feb. 11, 2000

Stroke news: Zanaflex reduces spasticity associated with stroke

Feb. 10, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...